Home > Boards > US Listed > Biotechs > Affimed Therapeutics (AFMD)

Today will be part 2 heading for $10.00-reconranger

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
reconranger Member Profile
Member Level 
Followed By 139
Posts 8,147
Boards Moderated 4
Alias Born 03/28/07
160x600 placeholder
Affimed Provides COVID-19-Related Business Update and Announces Full Year 2019 Financial Results Conference Call on April 28,... GlobeNewswire Inc. - 4/2/2020 6:30:00 AM
Affimed Announces FDA Granted Orphan Drug Designation for Lead Innate Cell Engager AFM13 for the Treatment of T-cell Lymphoma... GlobeNewswire Inc. - 4/1/2020 4:01:00 PM
Affimed Announces Participation at Upcoming Virtual Investor Conferences GlobeNewswire Inc. - 3/26/2020 7:30:00 AM
Affimed Announces Appointment of Arndt Schottelius, M.D. Ph.D. as Chief Scientific Officer GlobeNewswire Inc. - 3/17/2020 7:30:00 AM
Affimed to Present at the SVB Leerink 9th Annual Global Healthcare Conference GlobeNewswire Inc. - 2/19/2020 7:30:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2020 4:19:26 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/7/2020 8:51:29 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/3/2020 7:38:40 AM
Affimed Mourns Passing of Chief Financial Officer Dr. Florian Fischer GlobeNewswire Inc. - 2/3/2020 7:30:00 AM
Affimed Announces Appointment of Andreas Harstrick, M.D., as Chief Medical Officer GlobeNewswire Inc. - 1/10/2020 6:30:00 AM
Affimed Announces Addition to NASDAQ Biotechnology Index GlobeNewswire Inc. - 12/17/2019 7:30:00 AM
Affimed Reports Third Quarter 2019 Financial Results and Recent Operational Progress GlobeNewswire Inc. - 11/19/2019 7:30:00 AM
Affimed to Present at the Jefferies 2019 London Healthcare Conference GlobeNewswire Inc. - 11/14/2019 6:30:00 AM
Affimed Announces Third Quarter 2019 Financial Results and Corporate Update Conference Call on November 19, 2019 GlobeNewswire Inc. - 11/14/2019 6:30:00 AM
Affimed Announces Closing of Public Offering of Common Shares and Exercise of Underwriters’ Option to Purchase Additional S... GlobeNewswire Inc. - 11/13/2019 4:10:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/12/2019 4:14:49 PM
Affimed Announces Pricing of Public Offering of Common Shares GlobeNewswire Inc. - 11/8/2019 6:30:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/7/2019 5:12:51 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/7/2019 5:02:27 PM
Affimed Announces Proposed Public Offering of Common Shares GlobeNewswire Inc. - 11/7/2019 4:11:49 PM
Affimed Highlights Progress on NK Cell Engager Collaboration with Genentech GlobeNewswire Inc. - 11/7/2019 4:01:00 PM
Affimed Announces FDA Clearance of IND to Commence First-in-Human Phase 1/2a Study of AFM24 for the Treatment of EGFR-Express... GlobeNewswire Inc. - 11/7/2019 4:01:00 PM
Affimed Reports Progress on Key Clinical Development Programs GlobeNewswire Inc. - 10/15/2019 6:30:00 AM
Affimed to Participate in Investor Conferences in September GlobeNewswire Inc. - 8/28/2019 5:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/7/2019 8:24:54 AM
reconranger Member Level  Wednesday, 08/29/18 09:12:44 AM
Re: crudeoil24 post# 47
Post # of 88 
Today will be part 2 heading for $10.00-reconranger

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist